Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People with HIV who have higher viral load and worse immune function appear to be at higher risk for hepatocellular carcinoma.
Researchers compared liver-related death rates among Mexicans, Puerto Ricans and Cubans.
Better antiretrovirals have likely mitigated HIV’s effects on the risk of end-stage liver disease and liver cancer in those with hep C.
A new study examines the clinical and economic impact of new direct-acting antivirals.
Scientists aren’t sure, but they know that the risk that a previous case of liver cancer will return remains high for those cured of hep C.
This includes a higher risk of liver cancer, cirrhosis-related complications and death.
Non-alcoholic fatty liver disease can lead to cirrhosis and liver cancer.
The annual scientific meeting on liver health revealed exciting new findings concerning the battle against the hep C epidemic.
This is according to an analysis of nearly 5,000 Italians recently treated for the virus.
This is according to a recent mathematical modeling study.
Use of drugs like Nexium or Prilosec is tied to progression to cirrhosis, decompensated cirrhosis and liver cancer in this population.
A recent study in mice found that a high dose of green tea extract had a beneficial effect on a new sign of liver cancer progression.
Treatments to reduce inflammation could help make HIV even less of a threat to health than antiretrovirals can alone.
A new roundtable report summarizes key findings from recent studies outlining coffee’s likely contributions to protecting the liver.
Other factors linked to a reduced risk of death include a hep C cure, less advanced liver disease, not smoking and well treated HIV.
Men and people over age 50 still may still develop liver cancer after clearing the virus from the blood.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.